18 Sep 2020

Recent development in complex tablet formulation design

PDF 1.2 MB

In this article, Mathieu Degomme, PharmD, Pharmaceutical Development Project Manager, and Aline Moulin, PhD, Pharmaceutical Development Director, both of Skyepharma, outline three case studies from recent early-stage development programmes to illustrate what kind of complex tablets can be developed to meet specific target dissolution profiles for versatile applications.

Content provided by our supplier


  • FR
  • 2017
    On CPHI since

Other Content from SKYEPHARMA PRODUCTION S.A.S (1)